Aztreonam lysine: a novel inhalational antibiotic for cystic fibrosis

Update in Cystic Fibrosis 2008

(2009) Felix Ratjen   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Cystic Fibrosis Pulmonary Guidelines

(2009) Patrick A. Flume et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Pharmacokinetic and Pharmacodynamic Evaluation of Liposomal Amikacin for Inhalation in Cystic Fibrosis Patients with Chronic Pseudomonal Infection

(2009) O. O. Okusanya et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Efficacy of Aerosol MP-376, a Levofloxacin Inhalation Solution, in Models of Mouse Lung Infection Due to Pseudomonas aeruginosa

(2009) M. Sabet et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Determination of the Minimal Clinically Important Difference Scores for the Cystic Fibrosis Questionnaire-Revised Respiratory Symptom Scale in Two Populations of Patients With Cystic Fibrosis and Chronic Pseudomonas aeruginosa Airway Infection

(2009) Alexandra L. Quittner et al.   CHEST

Respiratory Microbiology of Patients With Cystic Fibrosis in the United States, 1995 to 2005

(2009) Samiya Razvi et al.   CHEST

Efficacy and Safety of Inhaled Aztreonam Lysine for Airway Pseudomonas in Cystic Fibrosis

(2009) George Z. Retsch-Bogart et al.   CHEST

Early anti-pseudomonal acquisition in young patients with cystic fibrosis: Rationale and design of the EPIC clinical trial and observational study,

(2009) Miriam M. Treggiari et al.   Contemporary Clinical Trials

Changes in Performance of the Pari eFlow® Rapid and Pari LC Plus™ during 6 Months Use by CF Patients

(2009) Bart L. Rottier et al.   Journal of Aerosol Medicine and Pulmonary Drug Delivery

Antibacterial activities of a fosfomycin/tobramycin combination: a novel inhaled antibiotic for bronchiectasis

(2009) D. L. MacLeod et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Barriers to asthma self-management in adolescents: Relationships to psychosocial factors

(2009) Hyekyun Rhee et al.   PEDIATRIC PULMONOLOGY

Clinic and radiological improvement of lipoid pneumonia with multiple bronchoalveolar lavages

(2009) Selma M.A. Sias et al.   PEDIATRIC PULMONOLOGY

Treatment of early Pseudomonas aeruginosa infection in patients with cystic fibrosis: the ELITE trial

(2009) F. Ratjen et al.   THORAX

Inhaled Aztreonam Lysine for Chronic AirwayPseudomonas aeruginosain Cystic Fibrosis

(2008) Karen S. McCoy et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Characterization of Nebulized Liposomal Amikacin (Arikace™) as a Function of Droplet Size

(2008) Zhili Li et al.   Journal of Aerosol Medicine and Pulmonary Drug Delivery

Effect of multiple aztreonam lysine for inhalation (AZLI) cycles on disease-related endpoints and safety in patients with cystic fibrosis (CF) and Pseudomonas aeruginosa (PA): Interim analysis of 12 month data

(2008) C. Oermann et al.   Journal of Cystic Fibrosis

High treatment burden in adults with cystic fibrosis: Challenges to disease self-management

(2008) Gregory S. Sawicki et al.   Journal of Cystic Fibrosis

Shifting patterns of inhaled antibiotic use in cystic fibrosis

(2008) Samuel M. Moskowitz et al.   PEDIATRIC PULMONOLOGY